Noile-Immune has been awarded the FY2025 Foreign Patent Application Cost Subsidy Program administered by the Tokyo Metropolitan Small and Medium Enterprise Support Center.

 This Subsidy program provides financial support to small and medium-sized enterprises that possess outstanding technologies and seek to actively utilize them in overseas markets.

 Noile-Immune has been strategically utilizing patent systems in various countries to secure intellectual property rights for our research outcomes in a timely and appropriate manner, not only in Japan but also internationally. Through this subsidy, Noile-Immune will further accelerate these efforts and strengthen our competitiveness in the global market.

Noile-Immune Biotech Inc.